Back to Connor, Clark & Lunn Investment Management Ltd. Connor, Clark & Lunn Investment Management Ltd.

CORTCORT

Showing 8 of 20 quarters

Position history for Connor, Clark & Lunn Investment Management Ltd.Connor, Clark & Lunn Investment Management Ltd.'s holdings in Corcept Therapeutics Incorporated

Yes. Connor, Clark & Lunn Investment Management holds 81,569 shares of CORT (Corcept Therapeutics), worth $7.1M, as of its Q2 2026 13F filing. It reduced the position by 36,385 shares (-30.9%) from Q1 2026. Connor, Clark & Lunn Investment Management has held CORT since Q3 2021, across 20 quarterly 13F filings.

Current Value

$7.1M

Current Shares

81,569

Total Value Change

-$32.7M

Total Shares Change

-777,994

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
81,569
-30.9%
$7.1M0.0%$86.95
0
2026-Q1
Decreased
117,954
-46.7%
$4.8M0.0%$40.31
0
2025-Q4
Decreased
221,444
-40.1%
$7.7M0.0%$34.80
0
2025-Q3
Increased
369,869
+16.3%
$30.7M0.1%$83.11
33
2025-Q2
Decreased
318,005
-57.7%
$23.3M0.1%$73.40
0
2025-Q1
Decreased
751,218
-5.7%
$85.8M0.4%$114.22
0
2024-Q4
Decreased
796,795
-7.3%
$40.2M0.2%$50.39
0
2024-Q3
Increased
859,563
+20.0%
$39.8M0.2%$46.28
41

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used